122 related articles for article (PubMed ID: 35842864)
1. Generating patient-derived ascites-dependent xenograft mouse models of peritoneal carcinomatosis.
Liu Y; Ng WH; Zhu HY; Tan QX; Hendrikson J; Tan JW; Ng G; Lim WK; Ong CJ
STAR Protoc; 2022 Sep; 3(3):101548. PubMed ID: 35842864
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study.
Li PC; Chen LD; Zheng F; Li Y
J Cancer Res Clin Oncol; 2008 Jan; 134(1):37-44. PubMed ID: 17665213
[TBL] [Abstract][Full Text] [Related]
3. Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Ohbatake Y; Fushida S; Tsukada T; Kinoshita J; Oyama K; Hayashi H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Yashiro M; Hirakawa K; Ohta T
Clin Exp Med; 2016 Nov; 16(4):585-592. PubMed ID: 26359244
[TBL] [Abstract][Full Text] [Related]
4. The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis.
Ströhlein MA; Heiss MM
Future Oncol; 2010 Sep; 6(9):1387-94. PubMed ID: 20919824
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancer.
Kasai S; Kuwayama N; Motoo Y; Kawashima A; Matsumoto K; Yano S; Matsushima K; Yasumoto K
Biochem Biophys Res Commun; 2022 Apr; 600():80-86. PubMed ID: 35196631
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
7. Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis.
Hendrikson J; Liu Y; Ng WH; Lee JY; Lim AH; Loh JW; Ng CCY; Ong WS; Tan JW; Tan QX; Ng G; Shannon NB; Lim WK; Lim TKH; Chua C; Wong JSM; Tan GHC; So JBY; Yeoh KG; Teh BT; Chia CS; Soo KC; Kon OL; Tan IB; Chan JY; Teo MCC; Ong CJ;
Cell Rep Med; 2022 Feb; 3(2):100526. PubMed ID: 35243423
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal regional chemotherapy with mitroxantrone.
Link KH; Hepp G; Staib L; Butzer U; Böhm W; Beger HG
Cancer Treat Res; 1996; 81():31-40. PubMed ID: 8834573
[TBL] [Abstract][Full Text] [Related]
9. Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice.
Martínez-Sabadell A; Ovejero Romero P; Arribas J; Arenas EJ
STAR Protoc; 2022 Dec; 3(4):101712. PubMed ID: 36317178
[TBL] [Abstract][Full Text] [Related]
10. A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma.
Hassan MS; Awasthi N; Li J; Schwarz MA; Schwarz RE; von Holzen U
PLoS One; 2017; 12(2):e0171824. PubMed ID: 28225784
[TBL] [Abstract][Full Text] [Related]
11. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.
Kuracha MR; Thomas P; Loggie BW; Govindarajan V
Cancer Med; 2016 Apr; 5(4):711-9. PubMed ID: 26833741
[TBL] [Abstract][Full Text] [Related]
13. The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.
Orgiano L; Pani F; Astara G; Madeddu C; Marini S; Manca A; Mantovani G
Support Care Cancer; 2016 Oct; 24(10):4293-9. PubMed ID: 27169699
[TBL] [Abstract][Full Text] [Related]
14. [Repeated intraperitoneal injection of low-dose CDDP for gastric cancer with ascites owing to peritonitis carcinomatosa].
Nakagawa M; Ninomiya M; Fujita I; Matsubara M; Okamoto Y; Kawamoto H; Araki Y; Inoue J; Sasaki H; Takakura N
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2346-9. PubMed ID: 12484071
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis in mouse models.
Arrizabalaga L; Di Trani CA; Risson A; Belsúe V; Gomar C; Ardaiz N; Berrondo P; Aranda F; Bella Á
Methods Cell Biol; 2024; 185():67-78. PubMed ID: 38556452
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease.
Golan T; Stossel C; Schvimer M; Atias D; Halperin S; Buzhor E; Raitses-Gurevich M; Cohen K; Pri-Chen S; Wilson J; Denroche RE; Lungu I; Bartlett JMS; Mbabaali F; Yarden Y; Nataraj NB; Gallinger S; Berger R
Oncotarget; 2017 Jun; 8(25):40778-40790. PubMed ID: 28489577
[TBL] [Abstract][Full Text] [Related]
17. [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients].
Ohgaki M; Takenaka A; Shiomi A; Chou H; Takashina K; Kawakami S; Fujita Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1858-60. PubMed ID: 15553739
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model.
Monneuse O; Mestrallet JP; Quash G; Gilly FN; Glehen O
J Gastrointest Surg; 2005; 9(6):769-74. PubMed ID: 15985231
[TBL] [Abstract][Full Text] [Related]
19. PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse.
Konishi H; Takagi A; Kurita A; Kaneda N; Matsuzaki T
BMC Cancer; 2012 Oct; 12():462. PubMed ID: 23046546
[TBL] [Abstract][Full Text] [Related]
20. Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer.
Kitayama J; Ishigami H; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
Oncology; 2010; 78(1):40-6. PubMed ID: 20197706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
